Guggenheim Capital LLC Enanta Pharmaceuticals Inc Transaction History

Guggenheim Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $462,981 - $748,970	-7,692 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $315,525 - $451,135	7,692 New	7,692 $437,000
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $896,051 - $1.16 Million	-13,699 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $220,144 - $325,529	2,576 Added 23.16%	13,699 $1.17 Million
Q2 2018 Aug 14, 2018	SELL	$81.85 - $120.51 $3.45 Million - $5.07 Million	-42,096 Reduced 79.1%	11,123 $1.29 Million
Q1 2018 May 15, 2018	BUY	$57.91 - $92.15 $2,490 - $3,962	43 Added 0.08%	53,219 $4.31 Million
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $1.16 Million - $1.51 Million	25,413 Added 91.54%	53,176 $3.12 Million
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $1.05 Million - $1.3 Million	27,763	27,763 $1.3 Million

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.